Dosing & administation

1500 IU Berinert vial saves time for healthcare professionals, patients or carers versus Berinert 500 IU2.

More information

1500 IU Berinert vial takes less than 6 minutes to reconstitute and administer2

What is Berinert?

Berinert is indicated for the treatment of: Hereditary angioedema type I and II (HAE). Licensed for use in neonates, infants and children – use in all ages.3,4

More information

Median patient-reported time (minutes) to onset of symptom relief5

Berinert
20 IU/kg (n=43)
30 Minutes
Placebo (n=42)
90 minutes

Onset of action was 30 minutes* following a single 20 IU/kg dose5

p=0.0025
*median

Resources

As part of CSL Behring’s ongoing support of the HAE community, a range of educational materials is now available for patients and healthcare professionals. These include practical information to assist both the specific use of Berinert and everyday management of HAE.

More information

References:
1. Craig TJ, et al. J Allergy Clin Immunol. 2011;66:1604–11. 2. CSL Behring, Berinert 1500 IU Data on file 1.0. 3. Berinert 500 IU SmPC. 4. Berinert 1500 IU SmPC. 5. Craig TJ, et al. J Allergy Clin Immunol. 2009;124(4):801–8.